$61.19
Currently 35 wall-street analysts regularly analyze the financials of Biomarin Pharmaceutical Inc. on a frequent basis to provide recommendations along with target share price. 35 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc. (BMRN) have a share price target of $88.48. This median of share price forecast represents a 44.6% upside from the latest price of $61.19 as on 21.12.25.
As per the chart shown above, analysts believe that the Biomarin Pharmaceutical Inc. (BMRN) share price will touch around $88.48 in next 12-months.
Below is a chart showing the percentage difference between Biomarin Pharmaceutical Inc.'s share price and its median forecast price. As on 21.12.25, the difference is -37.81%
Based on 35 analysts tracking and researching Biomarin Pharmaceutical Inc. (BMRN) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 15 | 15 | 16 |
| Outperform | 10 | 10 | 10 |
| Hold | 10 | 9 | 9 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |